Who benefits most from FDA’s ‘accelerated’ drug approvals? Patients or drugmakers?
“Jon Entine was truly an incredible and captivating speaker. A must see and hear phenomenon.”— Diane Scar, Jewish National Fund
Reach out to explore availability!